The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (Q107473785)

2

0 references

Ria Van Berwaer

3

0 references

Julie Vandeput

4

0 references

Isabel Marchand-Casas

5

0 references

Hendrik-Jan Thibaut

6

0 references

Dominique Van Looveren

7

0 references

Katleen Martens

8

0 references

Markus Hoffmann

9

0 references

Piet Maes

10

0 references

Stefan Pöhlmann

11

0 references

Lieve Naesens

12

0 references

Annelies Stevaert

Creative Commons Attribution 4.0 International

13

0 references

language of work or name

English

0 references

publication date

April 2021

0 references

published in

PLOS Pathogens

0 references

volume

17

0 references

issue

4

0 references

page(s)

e1009500

0 references

copyright license

start time

22 April 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Molecular pathology of emerging coronavirus infections

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Mechanisms of coronavirus cell entry mediated by the viral spike protein

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Evidence supporting a zoonotic origin of human coronavirus strain NL63

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS and MERS: recent insights into emerging coronaviruses

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Structure, Function, and Evolution of Coronavirus Spike Proteins

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic beta-cells

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Human coronaviruses 229E and NL63: close yet still so far.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro‐hepatocyte growth factor

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Phosphorylation of the type II transmembrane serine protease, TMPRSS13 in Hepatocyte Growth Factor Activator Inhibitor-1 and 2-mediated cell surface localization

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Airway proteases: an emerging drug target for influenza and other respiratory virus infections.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Nasal mucosal temperature during respiration.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SWISS-MODEL: homology modelling of protein structures and complexes.

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Thermal mapping of the airways in humans

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

A novel coronavirus outbreak of global health concern

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Virological assessment of hospitalized patients with COVID-2019

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Middle East respiratory syndrome

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Coronavirus membrane fusion mechanism offers as a potential target for antiviral development

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Cell entry mechanisms of SARS-CoV-2

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

10 July 2021

1 reference

https://api.crossref.org/works/10.1371/journal.ppat.1009500